
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
American Healthcare REIT Inc. demonstrated robust financial performance, characterized by a 4.1% year-over-year growth in rental rates and exceptional same-store NOI growth, particularly with the SHOP segment expanding by 25.3% and ISHC by 21.7%. The REIT has achieved the highest FFO growth rate within the Healthcare REIT sector, driven by favorable industry dynamics and proactive management strategies, especially after obtaining a superior cost of capital in late 2024. This advantageous position allows American Healthcare REIT to pursue aggressive investments, yielding projected two-year CAGR of 11.8% for Trilogy and 15.5% for SHOP, thereby enhancing its organic growth trajectory.
Bears say
American Healthcare REIT Inc. is facing a challenging outlook due to potential economic headwinds and regulatory changes that may adversely affect its tenants' operational performance, impacting the REIT's ability to meet earnings expectations. While leverage has decreased to 28.8% and net debt to annualized EBITDA has improved to 3.7x as of 2Q25, these metrics indicate financial stress and highlight an ongoing concern regarding the REIT's liquidity and ability to reinvest in properties. Additionally, the risk of lower Medicaid rates could significantly hinder growth prospects, suggesting a wary environment for future investments and earnings potential.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares